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Antibody-dependent cell-mediated cytotoxicity (ADCC)' is believed to play an
important role in the immunologic destruction of neoplastic cells, parasites,
virally infected cells, and foreign grafts, as well as in the pathogenesis of
autoimmune diseases (1-4). While the participation of macrophages, lympho-
cytes, and granulocytes in this process is widely recognized, the involvement of
platelets has only recently been appreciated.
The indication that platelets may mediate ADCC in vivo came with the
observation in irradiated mice that the growth of grafted lymphomas was sup-
pressed in the presence of platelets and anti-tumor antibody (5-7). Independ-
ently, the in vitro lysis ofantibody-sensitized chicken erythrocytes and ofhuman
erythrocytes and mastocytoma cells was briefly reported (2, 8). In an extensive
quantitative study, Soper et al. (9) showed that lysis ofantibody-sensitized SRBC
occurred in platelet-rich, C5-deficient plasma. The role of platelets and C3 was
demonstrated by the lack oflysis in C5-deficient platelet-poor plasma, and in C3-
depleted platelet-rich plasma (9). Others have reported (10) that human platelets
lyse cells from a human renal cell carcinoma line and a melanoma cell line
without added antibody. Platelet-mediated destruction of schistosomula in rats
has been reported to involve IgE (11) and C-reactive protein (12).
Recently, much progress has been made in our understanding of the mecha-
nism of effector cell activation by antibody and complement through the struc-
tural and functional characterization of receptors for these molecules (13-19).
Moreover, much work has been done to elucidate mechanisms of cytotoxicity;
these include the generation and action of toxic oxygen metabolites (20), pore-
forming proteins (21-23), and neutral proteases (24-27). In an effort to study
the mechanism of platelet-mediated cytotoxicity at a molecular level, we have
developed a plasma-free system where platelets lyse washed SRBC bearing
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'Abbreviations used in this paper:
￿
ADCC, antibody-dependent cell-mediated cytotoxicity; CVF,
cobravenom factor; DVBSG, dextrose-containing VBSG; EA,antibody-sensitized sheep erythrocytes;
EAC- 36, EA treated with C1 throughC3; EIgM,EIgG1, etc., EA with antibody of isotypeindicated;
LDH, lactate dehydrogenase; PPP, platelet-poor plasma; PRP, platelet-rich plasma; TLCK, tosyl-L-
lysine chloromethyl ketone; VBSG, veronal buffered saline with gelatin.
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defined molecular components. Our results demonstrate that antibody and C3,
in close proximity on target cell surfaces, synergistically activate the platelet for
cytotoxicity. Furthermore, our results suggest that the cytotoxic system capable
ofboth recognition and lysis resides in membranes.
Materials and Methods
Animals. 5-10-wk-old male AKR/J and 8-wk-old female BALB/cJ mice were pur-
chased from The Jackson Laboratory (Bar Harbor, ME).
Antibodies.
￿
Pooled rabbit polyclonal anti-SRBC antibody was prepared as outlined by
Kabat and Mayer (28), and fractionated rabbit polyclonal IgG and IgM anti-SRBC
antibodies were purchased from Cordis Laboratories Inc. (Miami, FL). The hemolytic
titers of these antibody preparations were determined as described (28). Mouse monoclo-
nal IgGI and IgG2b anti-SRBC, and IgE anti-DNP antibodies were from Pel-Freez
Biologicals (Rogers, AR). Hybridomas that produce mouse monoclonal IgG2a, IgG2b,
IgG3, and IgM anti-SRBC antibodies were obtained from American Type Culture
Collection (Rockville, MD) through the courtesy of Dr. William Raschke, La Jolla Cancer
Research Foundation (La Jolla, CA). Each of these antibodies was collected both from
culture supernatants and from ascites fluid that formed in BALB/cJ mice pretreated with
0.75 ml pristane (Aldrich Chemical Co., Milwaukee, WI) 3-20 d before injection of
hybridoma. Goat anti-mouse is chain antibody was purchased from Southern Biotechnol-
ogy Associates, Inc. (Birmingham, AL), goat anti-mouse C3 antibody was from Cappel
Laboratories (Malvern, PA), and rabbit-anti-goat IgG was from Kirkegaard & Perry
Laboratories, Inc. (Gaithersburg, MD).
Buffers.
￿
Tyrode's solution, pH 7 .3, contains 8 g NaCl, 0 .2 g KCI, 0.255 g CaC12, 0.1
g MgC12 -6H20, 0.0435 g NaH2PO4, 1 g glucose, and 1 g NaHCOs per liter. To make
Tyrode's gel-EDTA, 1 g gelatin and 40 ml of 0.1 M EDTA stock solution were added
per liter of Tyrode's solution. This solution was filtered through a 0.45-/m filter (Nalge
Co., Rochester, NY) and stored at 4° . Veronal-buffered saline with gelatin (VBSG) pH
7 .4, contains 8.3 g NaCl, 1 .0 g sodium barbital, 16 .7 mg CaC12, 0.20 g MgCl2-6H20, and
1 .0 g gelatin per liter. Dextrose-containing VBSG (DVBSG) consists of one part VBSG,
and one part 5% glucose solution with 0.1% gelatin. EDTA buffer, 0.01 M, was made by
adding one part 0.1 M stock EDTA solution to nine parts VBSG. Cacodylate buffer, pH
6.9, consists of 38.6 g cacodylic acid per liter. HBSS and RPMI 1640 were from Whittaker
M.A. Bioproducts (Walkersville, MD) and FCS was from HyClone Laboratories (Logan,
UT). TCM-10 medium was made by adding one part FCS to nine parts RPMI 1640.
Reagents and Plastiemare.
￿
All reagents were purchased from Sigma Chemical Co. (St.
Louis, MO) except as noted. Plastic Eppendorf tubes were from Brinkmann Instruments
Co. (Westbury, NY), plastic test tubes from Falcon Labware (Oxnard, CA), and 96-well
round-bottomed microtiter plates and plastic pipette tips were from Costar (Cambridge,
MA).
Platelets and C5-deficient Plasma.
￿
Mice were anesthetized by inhalation of methoxy-
flurane (Abbott Laboratories, N . Chicago, IL) and bled by cardiac puncture using a
heparinized 3-ml plastic syringe fitted with a 25-gauge needle. Final concentration of
heparin (Ivenex, Chagrin Falls, OH) was 15 U/ml blood. Whole blood was pooled into 3-
ml plastic test tubes and centrifuged at 90 g for 10 min. We used plasticware to avoid
agglutination. The resulting platelet-rich plasma (PRP) was spun at 6900 g for 20 min at
10'C. The supernatant, platelet-poor plasma (PPP), was removed and used as source of
complement, while the platelet pellet was resuspended in 700 Al Tyrode's-gel-EDTA and
centrifuged as above. The supernatant was removed and the washed pellet was resus-
pended to original volume, giving a solution of ^-107-108 platelets/ml, as counted in a
hemacytometer. There was C0.1% contamination with nucleated cells.
To disrupt platelets, they were sonicated three times on ice for 10 s pulses with a
Sonifier Cell Disruptor (No. W140; Ultrasonics, Inc., Plainview, NY), used at setting 5.
The sonicate was centrifuged at 12,000 g for 3 min and the pellet was brought to original
volume in Tyrode's-gel-EDTA. Both the supernatant and the resuspended platelets wereSLEZAK ET AL .
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assayed for cytolytic activity . In some experiments, sonicated platelets were further
disrupted by resuspending pellets in distilled water and incubating for 10 min at room
temp (29) . These water-shocked sonicated platelets were centrifuged at 12,000 g for 3
min and suspended in Tyrode's-gel-EDTA . Freezing and thawing consisted of placing
platelets in an ethanol-dry ice bath for 15 min, followed by thawing in a 37°C water bath
for 15 min . This was repeated twice for a total of three cycles . The whole lysate as well
as separated pellet and supernatant components were assayed for cytolytic activity .
Erythrocyte Targets . SRBC were obtained from a local dealer at 2-wk intervals and
stored at 4'C in citrate-dextrose . They were washed in 0.01 M EDTA and then twice in
VBSG . An aliquot of 100,1 packed SRBC was labeled with 300,Ci "Cr in a sterile saline
preparation (New England Nuclear, Boston, MA ; orAmersham Corp ., Arlington Heights,
IL), in a shaking, 37'C water bath for 1 h . The cells were centrifuged at 125 g for 5 min,
washed three times in saline, resuspended in 9.9 ml DVBSG at 10 8 cells/ml, and stored at
4°C for use within 1 wk .
To prepare antibody-sensitized erythrocytes (EA), 0.1 ml of "Cr-labeled SRBC stock
was mixed with 0 .1 ml antibody in VBSG and incubated with occasional agitation for 60
min at 30°C . To sensitize erythrocytes with both antibody and complement (EAC ^- 3b),
0.2 ml fresh C5-deficient PPP or serum was added to SRBC and antibody, and incubated
for 60 min . Cells were then washed twice and resuspended at 10' cells/ml . Unless
mentioned otherwise, heat-inactivated polyclonal rabbit anti-SRBC was used in preparing
EA or EAC ^- 3b as described (28) .
To hapten derivatize erythrocytes so that anti-DNP monoclonal IgE antibody could be
tested, 0.3 ml "Cr-labeled SRBC at 108 cells/ml were centrifuged at 125 g for 5 min and
the supernatant was removed . The cells were resuspended in 3.5 ml of 0.28 M cacodylic
acid, pH 6.9, containing 15 mg of 2,4,6-trinitrobenzene sulfonic acid . After a 10-min
incubation at room temperature, cells were washed three times in VBSG .
Cytotoxicity Assay.
￿
Serial dilutions of platelets in 25 u1 Tyrode's-gel-EDTA were made
in round-bottomed microtiter plates . Equal volumes of target cells at 10' cells/ml were
added, and the plates were incubated at 37 °C for 90 min with continuous shaking to keep
target cells in suspension (microorbital shaker, speed 6 ; Bellco Glass, Inc ., Vineland, NJ).
After incubation, 150 ,ul ice-cold Tyrode's-gel-EDTA was added to each well and the
plates were agitated for 15 s . Plates were centrifuged at 700 g for 10 min at 4°C and 100
A1 supernatant was assayed for "Cr release in a 4000 gamma counter (Beckman Instru-
ments, Inc ., Fullerton, CA) . The maximum number of counts was determined with 12.5
Al of labeled target cells .
When inhibitors were tested, they were added in 10-,1 volumes, as were control buffer
aliquots . The final incubation volume was 60 Al, and after incubation, 140 ul of Tyrode's
gel-EDTA was added . As before, 100,uI of supernatant was assayed for chromium release .
Quantitative Analysis ofData.
￿
In Figs . 2 and 3, the extent of target cell destruction was
calculated as percent lysis = 100 x (cpm sample)/(cpm maximum) . In all other cases, we
calculated it as percent specific lysis = 100 x [(cpm sample) - (cpm spontaneous)]/[(cpm
maximum) - (cpm spontaneous)] . All points shown are means of replicate experimental
trials . For duplicate values, the range was determined, and for other replicates, the
standard deviation was calculated . Error bars are used to indicate those deviations from
the mean that exceeded 5% .
Preparation of Cobra Venom Factor (CVF)-treated Plasma.
￿
5 U of CVF obtained from
Cordis Laboratories Inc . were injected intraperitoneally 18 h and 1 h before AKR/J mice
were killed . PPP was obtained as described above for untreated PPP .
Radioimmunoassay.
￿
Unlabeled SRBC, antibody-sensitizedSRBC, or antibody and com-
plement-sensitized SRBC were brought to 10 8 cells/ml in RIA buffer, a mixture ofVBSG
and an equal volume of TCM-10, and put in 100-Al aliquots in siliconized glass tubes
(VWR Scientific Div ., San Francisco, CA) . The cells were centrifuged at '700 g at 20 °C,
for 5 min, and the resulting pellet was resuspended with 1 ml ofa mixture ofFCS and an
equal volume of HBSS . Resuspended SRBC were layered over 0.5 ml RIA buffer and
centrifuged as before . The pellet was resuspended in 0 .1 ml RIA buffer .
Anti-mouse IgG, anti-a chain, or anti-C3 antibodies were iodinated ('s'I ; Amersham492
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FIGURE 1 .
￿
Platelet-mediated lysis in plasma-free system .
(/) Lysis of EAC - 36 by washed platelets in Tyrode's
solution containing 4 inM EDTA and 0.1% gelatin . ([I)
For comparison,EA was incubated in platelet-rich plasma .
Lysis ofEA incubatedin comparable concentrations ofC5-
deficient, platelet-poor plasma was <10% (data not
shown) . Each point represents the mean of duplicate
experiments . For definition of error bars, see Materials
and Methods .
Corp .) by the chloramine T method (30) and were added in 0.1-ml aliquots. After
incubation with occasional mixing for 1 h atroom temperature, the cells were centrifuged
and the pellet was washed as before . The number ofcpm remaining in the washed pellet
was determined in a 4000 gamma counter (Beckman Instruments, Inc .) .
Marker Assays .
￿
To determine lactate dehydrogenase (LDH) activity, 0.4-ml fractions
of'disrupted platelets were added to an equal volume of NADH (0.2 mg/ml in 0.1 M
Na3P0 4 , pH 7 .2) . After incubation for 20 min at room temperature, 0 .2 ml of pyruvic
acid (7 mg/10 ml in 0.1 M Na. 5P04 , pH 7 .2) was added, and the OD340 was immediately
recorded for 1 min . As a control, an equal number of intact platelets were completely
lysed by incubating in mellitin solution, 2 mg/ml, for 30 min at 37°C, and spun for 5
min . The supernatant was assayed as before to determine total LDH release .
The activity of N-acetyl-,3-n-glucosaminidase was measured as follows : 0.1-ml fractions
of disrupted platelets were added to the mixture of 0.8 ml of 0.05 M sodium citrate
buffer, pH 4.5, and 0.1 ml of 25 mM p-nitrophenyl N-acetyl (3-D-glucosaminide and were
incubated for 30 min at 37°C . The reaction was stopped with a I-nil solution of 1 M
NaOH and 0.5 M glycine, and OD4 5 was determined .
1 rim of [ 1H]serotonin (New England Nuclear) at 29.5 Ci/mmol was incubated with
platelets (10"/ml) at 37°C for 30 min (31) . Platelets were extensively washed before
disruption, and the serotonin activities remaining in resulting fractions were determined
in a scintillation counter (model LS 1800 ; Beckman Instruments, Inc .) .
Electron Microscopy.
￿
Frozen and thawed, sonicated, sonicated and water-shocked, and
intact control platelets were prepared as described above . All preparations were pelleted
at 12,000 g for 3 min, supernatants were carefully removed, and pellets were fixed in
freshly made 0.21 M cacodylate buffer, pH 7.4, containing 4% glutaraldehyde for 2 h at
25°C . The pellets were washed three times with ice-cold 0.21 M cacodylate buffer
containing 7.5% sucrose . The samples were further fixed in 1% osmium tetroxide for 60
rein at 4°C, dehydrated in a series of graded alcohols, and embedded in epon 812
(Electron Microscopy Sciences, Fort Washington, PA) . Thin sections, 80 nm thick, were
stained with uranyl acetate and lead citrate (Electron Microscopy Sciences) . Sections were
then examined with aJEOL 10 Cx microscope .
Results
Plasmafree System .
￿
To study the mechanisms of platelet-mediated lysis, we
first developed a system wherein washed platelets could lyse SRBC targets
sensitized with antibody and complement in a medium free of plasma . We
designate these targets as EAC ^- 3b . 2 As shown in Fig . 1, platelets were able to
lyse EAC - 3b in Tyrode's solution containing 0.1 % gelatin and 4 mM EDTA .
For comparison, we also measured the lysis of EA in C5-deficient platelet-rich
plasma, serially diluted in Tyrode's solution containing 0 .1% gelatin, but no
EDTA . At equivalent concentrations of platelets, lysis in our plasma-free system
was similar to that in the plasma-rich system .
i We used the designation EAC - 3b even though the active complement fragment may be some
cleavage product(s) of C3 other than C3b .FIGURE 2 .
￿
Effect of Ca", albumin, and gelatin in Tyrode's solution . (a) Tyrode's solution
with 0.1% gelatin contained 2mM Cas', no Ca", or 4mM EDTA ; (b)Tyrode's solution with
4 InM EDTA contained no gelatin, 0.1% human serum albumin, or 0.1% gelatin . Lysis of
EAC ^- 3b in solutions containing no platelets (open bar), platelets at 1 .25 x 10'/ml (hatched
bar), or 5 x 10'/ml (solid bar) . Each barrepresents the mean of two experiments .
0 30 60 90 120 150 180
time (minutes)
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FIGURE 3 . Kinetics of platelet-mediated
lysis . Lysis ofEAC ^- 3b was determined at
various times as indicated . Platelet concen-
trations were 8 x 10'/ml (/); 4 x 10'/ml
(El) ; 2 x 10'/ml (A) ; and I X l0'/ml (A) . 1n
control (g) no platelets were added. Each
point is the mean of three experiments .
We initially used simple Tyrode's solution without EDTA or gelatin, and
observed high spontaneous lysis and frequent agglutination of target EAC - 3b
in this solution . Elimination of calcium from Tyrode's solution (Fig . 2a) and
addition of small amounts of protein such as gelatin or albumin (Fig . 2 b) resolved
these problems . Therefore, unless mentioned otherwise, in all our experiments
we used Tyrode's solution containing 4 mM EDTA and 0 .1% gelatin (Tyrode's-
gel-EDTA) .
￿
'
Kinetics and Dose Response of the Lytic Reaction .
￿
The kinetics of the lytic
reaction was examined at several concentrations of platelets . As shown in Fig . 3,
a significant lag period preceded lysis, plateau levels were reached by 120 min,
and the extent of lysis depended on the concentration of platelets. In other
experiments (data not shown),the lag period was shorter and plateau levels were
attained sooner, e.g ., by 60 min . For routine assay of platelet-mediated lysis,
reactions were terminated after 90 min of incubation . When lysis of targets is
plotted as a function of platelet concentration, the dose-response curve is entirely
concave to the abscissa, as shown in Fig . 4 . In only 2 of 15 experiments, the
dose-response curves were not concave to the abscissa (e .g ., Fig . 1) . Because of
this occasional variability, additional experiments were performed so that lysis at
several low platelet concentrations could be examined more thoroughly . The494
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FIGURE 4 .
￿
Dose-response curve
of lysis as a function of platelet
concentration .Thedose-response
curve was obtained by plotting
percent specific lysis at 120 min
from the experiment shown in
Fig. 3, as a function of platelet
concentration . Target cell con-
centration, as in all other experi-
ments, was 10'/ml. Lysisof target
cells at low platelet concentrations
was examined in a different trial
shown in the inset . Each point in
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FIGURE 5 .
￿
Kinetics of platelet-mediated lysis at
differenttemperatures. Lysiswas measured at 37'
(/); 22° (Q); and 4° (A). The platelet concentra-
tion was 10"/ml . Each point represents the mean
of twoexperiments .
result is shown in the inset of Fig . 4 . Again, as in most of our experiments, the
dose-response curve is entirely concave to the abscissa . These results indicate
that the process of platelet-mediated lysis is a one-hit reaction, where a fruitful
interaction between one platelet and one target cell leads to lysis . If all platelets
have functional lytic capacity under the assay conditions used, one would expect
that, at a platelet-to-target cell ratio of one-to-one, lysis would be 63% based on
the Poisson distribution . Results from 15 experiments indicate that in one case
lysis failed to reach 63%, even at the highest platelet-to-target ratio that was
tested, which was 5 to 1 . In the remaining cases, ratios ranged between 0.5 and
7 ; most of them clustered between 0 .5 and 2, giving an average ratio of 1 .3 .
Fffect of Temperature on Lytic Reaction.
￿
The effect of temperature on the
kinetics of iysis was also investigated . As shown in Fig . 5, therate of lysis increased
as temperature wasraised . Becauseof difficulty in determining the initial reaction
velocity, the extent of lysis at 60-min time points was analyzed as a function of
temperature . We calculated Z values, defined to be the average number of lethal
platelet interactions per target cell (32), where Z = -In (1 - fraction of specific
lysis) . Changing temperature from 4° to 22°C increased lysis from 6 to 25%,
andZ values from 0.06 to 0.29. Raising temperature from 22° to 37°C increased
lysis from 25 to 62%, and Z values from 0.29 to 0.97 . The Q,() values calculated
from changes in Z values are therefore 2 .4 in going from 4' to 22'C, and 2 .2
for the change from 22° to 37°C . From another experiment of similar design,
Q, is 1 .3 (4° to 22°C) and 2.1 (22° to 37°C) . The average Q,o is 2 .0 .too4
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with different isotypes ofantibody in
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presence (solid bar) of C5-deficient plasma, washed, and tested for lysis by platelets. Platelet
concentration was 5 X 10'/ml . Each bar represents the mean of twoexperiments .
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i 1 through C3 . (a) SRBC were sensi-
1 I bodies of indicated isotypes at con-
Role ofAntibody and Complement .
￿
We investigated whether or not sensitization
of' targets with antibody alone would be sufficient to induce platelet-mediated
lysis, and what role complement might play in the reaction .
We first examined the activity of mouse mAbs of different isotypes . All of the
antibodies used, namely IgM, IgGI, IgG2a, IgG2b, IgG3, and IgE, had K light
chains . For comparative studies shown in Fig . 6a, SRBC were sensitized with
antibodies of the different isotypes to generate comparable amounts of cell-
boundantibody, as measured by the binding of í25I-labeled anti-tc chain antibody .
We observed 21% lysis of targets sensitized with IgG2a alone, and <5% with
other isotypes alone. Even with 30 times more cell-bound IgG2a than that shown
in Fig . 6 a, lysis did not exceed 21% . The low degree of lysis of SRBC sensitized
with IgM, IgG3, or IgE, as shown in Fig . 6a, was not seen in several other
experiments .
In contrast, when antibody-sensitized target cells were treated with C5-defi-
cient mouse plasma, those with isotypes IgG2b or IgG3 were now lysed by
platelets, and lysis of target cells sensitized with IgG2a was enhanced . Isotypes
IgG 1, IgM, and IgE were inactive with or without added complement even with
20 times more cell-bound antibody . The low-level lysis of IgM- or IgE-sensitized
EAC- 3b targets, i .e . 5-7% in Fig . 6a, was not seen in several otherexperiments .
Thus, among the complement-activating isotypes, namely IgM, IgG2a, IgG2b,
and IgG3, only IgM was inactive . Next, the role of C3 in platelet-mediated lysis
was evaluated . The platelet-mediated lysis of control target cells sensitized with
monoclonal IgG2b and treated with C5-deficient plasma was 63% at platelet
concentrations of 5 x 10'/ml, whereas treatment with plasma that had been C3-
depleted by CVF resulted in no lysis even when platelet concentration was
increased to 10'/ml (data not shown) . The critical role ofC3 in the lyric process
is therefore implicated .
We examined the activity of polyclonal antibodies of IgM and IgG isotypes,
used at comparable hemolytic titers . As shown in Fig . 6 b, 25% of targets treated
with polyclonal IgG alone were lysed, and 99% of targets were lysed in the
presence of complement . Under comparable experimental conditions, lysis of
target cells sensitized with IgG alone ranged between 0 and 32% in 12 cases,
and only in one case did lysis reach 62% . Further treatment with C5-deficient
plasma, but not C3-depleted plasma, consistently increased the degree of lysis .496
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TABLE I
Requirementfor Close Proximity between Cell-bound IgG and C3b in Triggering
Platelet-mediated Lysis
* Each value represents the mean of two experiments.
$Tested at platelet concentration of 5 X 10'/ml . Each value represents mean of two
experiments . In two other trials, similar results were obtained, i.e ., no lysis except for
EIgG2bC-36 .
4 Not done . In another experiment, the value was similar to the combined counts of
EIgMC-3b and EIgG2bC---36 .
Target cells treated with polyclonal IgM, with or without C5-deficient plasma,
were not lysed by platelets (data not shown) . Hence these results are consistent
with those obtained with mAbs .
Spatial Relationship between Cell-bound IgG and C3 Fragment Triggering Platelet-
mediated Lysis . The studies described in the preceding section indicated a
requirement for activated cell-bound C3, presumably C3b . We investigated
whether or not theproximity of cell-bound IgGandC3baffects platelet-mediated
lysis . For this purpose, we used mouse monoclonal IgG2b and IgM . Cell-bound
IgG2b, together with C3b, induced platelet-mediated lysis, whereas mouse mono-
clonal IgM generated cell-bound C3b but failed to induce lysis . As shown in
Table 1, more IgG2b than IgM was needed to generate comparable amounts of
cell-bound C3b on SRBC . These target cells are designated as EIgG2bC ^- 3b
and EIgMC - 3b, respectively . We sensitized aliquots of EIgMC ^- 3b with
IgG2b . This cell preparation is designated as EIgMC - 3b + IgG2b . Only
EIgG2bC ^- 3b and not EIgMC ^- 3b + IgG2b was lysed, despite the fact that
EIgMC - 3b + IgG2b had comparable amounts of cell-bound C3b and IgG2b .
It is possible that when complement is activated by appropriate cell-bound
antibodies, C3b molecules are deposited near antibody molecules and only these
C3b can activate platelets in cooperation with the appropriate isotypes of anti-
body . When washed EIgMC -., 3b is treated with IgG2b, the sites where freshly
added IgG2b bind may be too far from the already-bound C3b molecules to
induce lysis .
Lack of Effect of Protease Inhibitors on Lytic Activity .
￿
Proteases have been
implicated in the cytotoxic reactions mediated by macrophages, neutrophils, and
cytolyticT cells (24-27) . We tested inhibitors of proteases that included leupep-
tin, tosyl-t.-lysine chloromethyl ketone (TLCK), PMSF, aprotinin, and several
trypsin inhibitors . As seen in Fig . 7, there was no significant inhibition of lysis
by 0.2 mM PMSF or 0.2 mM TLCK . Similarly, I mM leupeptin had no inhibitory
Target cells
Radioactivity
Anti-IgG
after treatment
antibodies*
Anti-K
chain
with labeled
Anti-C3
Platelet-
mediated
lysisT
cpm
EIgM 3,520 6,479 1,509 1
EIgG26 210,471 27,517 8,997 2
EIgMC-3b 10,372 5,902 193,622 1
EIgG2bC-36 218,470 27,007 214,240 72
EIgMC---36+IgG2b 180,189 NDO 193,868 0
None 490 608 1,262N
N
U
U a,
N
a
'
N
m
U
U
N
G
N
0
100
60
60
40
SLEZAK ET A1 . .
FIGURE 7.
￿
Effect of protease inhibitors on lysis .
Platelets were incubated with EAC ^- 3b and 0.2
mM TLCK (p) ; 0.2 mM PMSF (A) ; or buffer (0).
Each point represents the mean of two experi-
ments .
platelets / ml (x 10
FIGURE 8.
￿
Evaluation ofthe role of toxic oxygen metabolites . (a) Platelet-mediated lysis was
tested in buffer (0); superoxide dismutase, 10 Fig/ml (p) ; or mannitol, 25 mM (A) . (b) Platelet-
mediated lysis in buffer (0); catalase, 50 wg/ml (p) ; or catalase, 500mg/ml (A). (c) Glucose was
deprived from platelets and target cells during 2-h preincubation in glucose-free buffer, and
then lytic activity was tested in glucose-free buffer (p) . As a control, untreated platelets were
tested for lysis of target cells in usual glucose-containing buffer (/) . (d) Lytic activities were
compared in the absence (0) or presence (p) of 10 juM cytochalasin B; or 100 yM cytochalasin
B(A). Each point represents the mean of two experiments.
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effect . We observed no significant inhibitory activity with 1 mM aprotimn, 0.75
mM soybean trypsin inhibitor, 1 mM lima bean trypsin inhibitor, or 1 mM
chicken egg white ovomucoids types 11-0 or 111-0 (data not shown) . The concen-
trations of inhibitors and cells used here are similar to those used in other cellular
systems, such as neutrophils and macrophages (24, 25) . Because of the small size
of platelets compared with leukocytes, platelets were exposed to greater amounts
of inhibitors on a per cell mass basis .
Evaluation of the Role of Toxic Oxygen Metabolites.
￿
The toxic metabolites of
oxygen have been shown to cause target cell lysis by other effectors (20) .
Superoxide dismutase, catalase, and mannitol did not affect platelet-mediated
lysis (Fig . 8, a and b) . Platelets preincubated in glucose-free medium or cytochal-498
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FIGURE 9. Lack of bystander
lysis by platelets . "Cr-labeled
erythrocytes (*E) or antibody-
sensitized targets (*EA) were in-
cubated with platelets in the pres-
ence or absence ofequalnumbers
of unlabeled EAC - 3b targets to
determine whether or not the ra-
diolabeled bystanders were lysed .
Control labeled targets (*EAC
3b) were incubated with platelets
at the same concentration of 1 .7
X 10'/ml . Each bar represents the
mean of four experiments .
asin B-containing medium and tested in these media displayed no change in
cytolytic activity (Fig . 8, c and d) .
Lack ofBystander Target Cell Lysis .
￿
When labeled E or labeled EA were mixed
with unlabeled EAC ^- 3b, lysis of labeled cells, if any, was not affected by the
presence of unlabeled target EAC - 3b, as shown in Fig. 9 .
Effect of Freezing and Thawing on Lytic Activity .
￿
We have found that platelets
kept frozen at -70'C for >4 mo retain cytotoxic activity . To determine the
effects of freezing more precisely, freshly isolated platelets were frozen and
thawed three times over a 90-min period . The frozen and thawed preparation
was centrifuged and the pellet was then suspended to the original volume . An
assay for lactate dehydrogenase activity showed that the supernatant contained
106% of the activity of control platelets lysed with mellitin, while the pellet had
only 3% activity . Thus, the platelet cytoplasmic contents were totally released by
freezing and thawing . Electron microscopic examination showed that the pellet
contained platelets with reduced cytoplasmic and granular contents (compare
Fig . 10,A and B) . These morphologic findings were supported by the retention
of 34% of N-acetylglucosaminidase activity (lysosomal marker) and 21% of
radiolabeled serotonin (dense granule marker) in pelleted, frozen and thawed
platelets compared with untreated controls . Remaining activities were entirely
recoverable in the supernatant . As shown in Fig . 11 a, cytolytic activity in the
particulate fraction of frozen and thawed platelets was comparable to that of
intact platelets . In contrast, little activity was found in the supernate . In four of
four experiments, >75% lytic activity was recovered after freezing and thawing .
As with freshly isolated platelets, frozen and thawed platelets lysed EAC ^- 3b
but not E.
Effect of Sonication on Lytic Activity .
￿
Platelets were disrupted by three rounds
of sonication and separated into pellet and supernate by centrifugation . The
pellet was resuspended to original volume . The supernate contained 100% of
LDH activity, indicating that the platelets' cytoplasmic contents were totally
released . As shown in Fig . 11 b, the lytic activity of the sonicated, pelleted
platelets was less than that of intact platelets by ^-50% . Sonicated platelets
specifically lysed EAC - 3b and not E. Lytic activity of the supernatant was
negligible, in that even the undiluted supernatant caused <10% lysis of target
cells . Electron microscopic examination showed that sonication disrupted plate-
lets into small membrane vesicles with markedly diminished cytoplasmic andSLEZAK ET AL .
￿
499
FIGURE 10 .
￿
Electron micrographs of (A) intact ; (B) frozen and thawed; (C) sonicated ; and
(D) sonicated and water-shocked platelets . (A and B) X 11,250 ; (C and D) X 22,500 .
granular contents (Fig . 10C) . Assays for granule markers showed that the
pelletable platelet fraction retained only 19% of total N-acetylglucosaminidase
activity and 7% of total serotonin . In another experiment, sonicated platelets
were given a hypotonic shock by exposing them to water. The lytic activity
relative to intact platelets was similar to that of sonicated but not water-shocked
platelets (data not shown) . Likewise, the water-shocked plateletsappeared similar
by electron microscopy to sonicated platelets (Fig . 10D) . Again, these morpho-
logic findings were supported by granule marker assays, with 13% of total N-
acetylglucosaminidase activity and 6% of total serotonin found in the pelleted
fraction .
Effect of Heat or Trypsin on Lytic Activity ofPlatelets.
￿
Platelets were heated at
37'C for 60 min, 56'C for 60 min, or 100'C for 2 min and then lytic activities
were tested . Compared with lytic activity of platelets kept at 0 °C for 60 min,
activity was not lost by 37"C treatment . On the other hand, heating at 56' or
100'C resulted in virtually complete loss of activity, as shown in Fig . 12a.500
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platelets/ ml (z l07 )
0
FIGURE 11 .
￿
Effect of freezing and thawing or sonication on platelet lytic activity . (a) Platelets
were frozen andthawed, and tested for lytic activity with E (*) or EAC ^- 3b ([I). Thefrozen
and thawed preparation was centrifuged and the resuspended pellet was assayed for lytic
activity with E (0) or EAC - 3b (A). The lytic activity of the supernatant did not exceed 10% .
Untreated intact platelets (E) were assayed for lytic activity with EAC - 3b as a control . Each
point represents the mean of two experiments . (b) Platelets were sonicated three times and
separated by centrifugation into pellet and supernate . The pellet was resuspended to the
original volume . The lytic activity of sonicated platelets with EAC - 3b (p) was compared
with that ofequivalent concentrations of intact platelets (/) . As another control, the lysis of E
was tested with sonicated (") or sonicated and pelleted platelets (0) . The lytic activity of
undiluted as well as diluted supernatant didnot exceed 10%. Each point represents the mean
of twoexperiments .
FIGURE 12 .
￿
Effect of heat or trypsin on platelet lytic activity . (a) Platelets were kept at 0° ,
37 ° , or 56 °C for 1 h, or at 100°C for 2 min, before assay for lytic activity . (b) Platelets were
treated with trypsin at 0.01% ([I) or 0.001% (A) for 45 min and washed before assay for lytic
activity. Controls incubated with buffer (/) were also tested . Each point in both panels
represents the mean of two experiments .
Platelets (8 X 108/ml) were incubated in buffer containing 0.001% or 0 .01
trypsin at 37°C for 45 min . After incubation, the reaction medium was diluted
fivefold and platelets were sedimented . Supernatants were saved and cells were
washed once more in Tyrode's-gel-EDTA before assay for lytic activity, so that
the possibility of trypsin carry-over was minimized . By light microscopy, platelets
appeared normal and platelet numbers were not diminished after trypsin treat-
ment . As shown in Fig . 12 b, lytic activity was markedly diminished after 0.001%
or 0.01% trypsin treatment . In anotherexperiment where trypsin was neutralized
with excess soybean trypsin inhibitor (0.06%), we observed a similar loss of lytic
activity . Supernates did not contain any lytic activity for EAC ~ 3b or E .SLEZAK ET AL.
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Discussion
The participation of platelets in the destruction of antibody-coated targets
such as SRBC, neoplastic cells, andschistosomal larvae has been appreciated only
recently. The possible involvement ofplatelets in autoimmune disease has been
implicated as well (33). To understand platelet-mediated cytotoxicity at a molec-
ular level, we have developed a plasma-free experimental system which enabled
us to studya numberofparameters ofthe reaction underwell-defined conditions.
In the plasma-free system, we have used washed platelets and SRBC targets
sensitized with antibody or antibody and C1 through C3. Lytic efficiency in our
system and in the platelet-rich plasma system described by Soper et al. (9) was
similar. In most cases we found that the dose-response curve oflysisas a function
of platelet concentration is entirely concave to the abscissa, indicating that a
fruitful interaction between one effector and one target cell can lead to lysis.
Results from numerous experiments indicate that the actual number ofplatelets
needed to lyse a single target was in most cases about one. Our previous in vivo
experiments (5-7) showed that several hundred platelets per neoplastic cell
caused suppression of tumor growth. Whether or not the efficiency of in vivo
destruction of neoplastic cells could be improved to the level of efficiency
observed in vitro needs to be studied. In any case, considering the vast number
of platelets in blood, the platelet is a major cytotoxic resource. The lag period
preceding lysis suggests that multiple reaction steps ensue before lysis occurs.
Temperature changes had a minor effect on lysis, i.e., Qio of 2. Further studies
are needed to determine the mechanistic significance ofthis observation.
We noted that target SRBC treated with subagglutinating doses of antibody
alone (EA) were poorly lysed or not lysed at all. Only polyclonal rabbit IgG and
monoclonal IgG2a were active, but even with these antibodies, lysis was limited.
It is possible that interaction of certain isotypes of IgG, e.g., IgG2a, with
appropriate Fc receptors can deliver a signal for the activation of platelet
cytotoxicity, albeit an incomplete one. Interestingly, the interaction between
IgG2a and its Fc receptor is believed to occur with higher affinity than those
between other antibody classes and their respective Fc receptors (34). The
reasons for limited activity by polyclonal IgG are more difficult to surmise,
because of the heterogeneity ofIgG antibodies in that preparation.
Experiments using C5-deficient plasma with and without cobra venom treat-
ment, both in our studies and in those of Soper et al. (9), have implicated the
role of C3 in triggering the lytic process. In support of this conclusion, we have
found thatonly IgG2a, IgG2b, and IgG3, isotypes knowntoactivate complement,
were active in the reaction . However, in the study of Soper et al., non-
complement-fixing isotype IgG1 was also active. Whether or not in our experi-
ments a higher concentration of IgGI might have triggered lysis could not be
tested adequately because of target cell agglutination with more antibody. It is
also ofinterest that we have previously shown (7) IgG1 to be active in initiating
platelet-mediated tumor suppression in vivo. What factors, if any, influence
activity of IgGI in vitro and in vivo remain to be elucidated.
Our studies with IgM show that even though C3 was fixed on target cell
surfaces in the presence ofthis antibody, lysis did not occur. Since an Fc receptor
for IgM has not been identified on cytotoxic effector cells, interaction oftarget502
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cells and platelets would have taken place by means of complement receptors
alone. This single type of interaction therefore is not sufficient for platelet
activation. However, when equivalent amounts of C3 were fixed on target cell
surfaces by IgG isotypes, e.g., IgG2b as in Table 1, the two different cell-bound
ligands could efficiently trigger platelet cytotoxicity. Thus, only those isotypes
capable both of fixing complement and interacting with platelet Fc receptors
could trigger efficient lysis.
It appears that efficient activation was achieved when thetwo different ligands,
IgG and C3b, were adjacent to each other. Thus, IgG2b-sensitized target cells
treated with complement were lysed, while target SRBC bearing equivalent
amounts ofcell-bound C3b generated by IgM and then sensitized with IgG2b,
presumably at sites distant from the bound C3b, were not lysed. This observation
in turn suggests that receptors for both ligands must be adjacent for efficient
lysis to occur. Interestingly, C3b receptors and Fc receptors on human neutro-
phils have been reported to co-cap when either receptor was crosslinked by
ligand (35).
It was reported by other investigators (11) that IgE could initiate platelet-
mediated destruction ofschistosomula, whereas we could not demonstrate plate-
let lysis of IgE-sensitized SRBC. One explanation for this apparent discrepancy
could be that different targets are lysed by different mechanisms and that IgE
triggers cytotoxic reactions mainly appropriate for parasitic targets.
We sought to elucidate the biochemical mechanism involved in platelet-
mediated lysis ofSRBC. Granularcytolysin orperforin isnotlikely to be involved,
given the strict calcium requirement for formation ofactive cytolysin complexes
(21-23), in contrast to the lack of a calcium requirement in platelet-mediated
lysis. Our evidence suggests that proteases and toxic oxygen metabolites do not
play a significant role in the lytic process.
In our initial effort to characterize the biochemical nature ofthe lytic system,
wehavefoundactivity in the particulate fraction offrozen and thawed, sonicated,
or sonicated and water-shocked platelets. The LDH release data clearly indicate
that the cytoplasmic contents of platelets are not involved in the lytic reaction.
The retention of lytic activity in sonicated and water-shocked platelets, as well as
the absence of intact granules as shown by electron microscopy and marker
assays, show that granular contents also are not involved. These results suggest
that the entire recognition and lytic system is associated with the membranes of
platelets. The lack ofan innocent bystander effect is compatible with this notion.
Isolation of these components from membranes and reconstitution of activity
into liposomes would be needed to verify our proposal. The observation that
heat or trypsin inactivates lytic function indicates that at least one involved
component is protein. It is encouraging that the intact system can survive
procedures such as freezing and thawingorsonication. Currently weare attempt-
ing to isolate the active components by various biochemical fractionation meth-
ods.
Summary
Platelets are one ofseveral cell types capable ofmediating antibody-dependent
cellular cytotoxicity. We have developed a plasma-free system in which washedSLEZAK ET AL.
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mouse platelets lyse washed antibody and complement-sensitized SRBC targets
in the presence of EDTA. The dose-response curve is concave to the abscissa,
indicating that lysis is a one-hit reaction. Determination of the actual number of
platelets required to lyse a target shows that each platelet could lyse a single
target. A limited degree of lysis is observed when platelets are incubated with
SRBC sensitized with monoclonal IgG2a alone, but no lysis occurs with SRBC
bearing comparable amounts of other isotypes. In the presence of C 1 through
C3, but not C1 through C2, efficient lysis is triggered by complement-fixing
monoclonal IgG2a, IgG2b, and IgG3. In contrast, IgM and non-complement-
fixing IgGI and IgE are inactive. To achieve efficient lysis, it appears that
platelets require both target cell-bound antibody and C3 fragments in close
proximity. It is unlikely that proteases, pore-forming proteins, or toxic oxygen
metabolites are involved in platelet-mediated lysis. Freezing and thawing of
platelets, sonication, or sonication followed by hypotonic shock causes severe
depletion of cytoplasmic and granular contents, as shown by electron microscopy
and marker assays. However, the membrane fraction of these preparations retains
cytolytic activity. When platelets are treated with trypsin or heated, lytic activity
is eliminated, indicating that at least one component of this system is protein.
These findings, as well as the fact that platelets do not lyse unsensitized innocent
bystander SRBC, suggest that the complete cytotoxic system of platelets capable
of specific recognition and lysis resides in their membranes.
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